(Q35913934)

11 August 2017

1 reference

title

Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease (English)

1 reference

11 August 2017

0 references

1

Gary R Lichtenstein

1 reference

11 August 2017

2

Stephen B Hanauer

1 reference

11 August 2017

Sunanda V Kane

3

1 reference

11 August 2017

Daniel H Present

series ordinal

4

1 reference

11 August 2017

publication date

1 July 2004

1 reference

Inflammatory Bowel Diseases

11 August 2017

published in

1 reference

11 August 2017

volume

10 Suppl 2

1 reference

11 August 2017

page(s)

S2-10

1 reference

Long-term evolution of disease behavior of Crohn's disease

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Disease activity courses in a regional cohort of Crohn's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Tolerability of aminosalicylates in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Evolving treatment strategies for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Preliminary study of ciprofloxacin in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Double blind, placebo controlled trial of metronidazole in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

The role of antibiotics in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Fluoroquinolones and risk of Achilles tendon disorders: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

How to do without steroids in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Corticosteroids in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

The use of budesonide in the treatment of active Crohn's disease is good clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Corticosteroid-sparing treatments in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Management of Crohn's disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Patient compliance and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Ulcerative colitis and colorectal cancer. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Colorectal cancer prevention in ulcerative colitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200407002-00002

10.1097/00054725-200407002-00002

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference